Welcome to our dedicated page for Syra Health news (Ticker: $SYRA), a resource for investors and traders seeking the latest updates and insights on Syra Health stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect Syra Health's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of Syra Health's position in the market.
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) expands cybersecurity offerings to support healthcare customers, aiming to improve healthcare by providing innovative services and technology solutions. The company addresses the critical need for cybersecurity in healthcare, citing a 2020 HHS Report on cybersecurity that highlights the impact of ransomware attacks and breaches on health organizations and patient data.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.48%
Tags
-
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) is sponsoring the ViVE Digital Health Event in Los Angeles California, February 24-28, 2024. The company offers innovative healthcare technology solutions, including mental and behavioral health products, AI-backed chatbots, cybersecurity solutions, and healthcare workforce solutions. Syra Health's CEO, Dr. Deepika Vuppalanchi, will be in attendance at ViVE.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Syra Health Corp (NASDAQ: SYRA) has achieved significant milestones in 2023, including launching innovative products and securing new contracts across its six business units. The company also expanded into federal government contracts, saw a 4% increase in third-quarter revenue, and a rise in gross profit margins from 27.3% to 35.1% compared to the previous year. Dr. Deepika Vuppalanchi, CEO, expressed pride in the team's commitment, while Sandeep Allam, Executive Chairman and President, emphasized the company's focus on delivering solutions to current and new audiences in 2024.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
7.78%
Tags
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) expands into its 15th state with a contract awarded by the Mississippi Department of Human Services to provide behavioral and mental health services for the Oakley Youth Development Center. The company will implement a comprehensive evaluation and treatment program, including the participation of licensed psychologists. This marks Syra Health's third engagement in three states for providing mental and behavioral health evaluation services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.93%
Tags
-
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) announced the expansion of its healthcare workforce business unit to include additional offerings. The expanded products and services aim to improve healthcare by providing innovative services and technology solutions. This includes healthcare workforce training, development, and education, a workforce technology platform for employers and job seekers, and healthcare workforce engagement and concierge services. The company also offers apprenticeship programs for those new to the healthcare workforce. The expansion is a natural progression of the company's expertise, with a focus on addressing the healthcare workforce shortage and creating a supportive workplace environment.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.6%
Tags
-
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) announces participation in upcoming healthcare conferences, including JP Morgan Healthcare Conference, ViVE Digital Health Tech Conference, and HIMSS Global Health Conference and Exhibition. Management will meet with investors at JP Morgan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
2.23%
Tags
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) is expanding its reach beyond state and local government agencies to supply its products, services, and solutions to the federal government. The company is hiring additional subject matter experts and a federal contracting team to implement its federal solutions. Syra Health currently has 13 active contracts across 12 states nationwide, supplying state and local governments with clinical staffing, mental and behavioral health solutions, and population health services.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) recently announced its contract win with Osawatomie State Hospital and Adair Acute Care in Kansas, marking its 13th active contract in 12 states. The company will deploy licensed professionals to deliver vital social and therapy services at Osawatomie State Hospital, focusing on discharge planning and therapy for patients with psychiatric disorders.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-5.51%
Tags
-
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) announced its Q3 2023 financial results, revealing a 4% increase in revenue to $1.58 million. The company reported its first period of revenues from its Digital Health unit and saw significant growth in Population Health and Health Education. Despite a net loss of $(354,376), the company secured several strategic agreements and closed a successful IPO financing of $6.7 million. Syra Health's gross profit margin improved to 35.1% from 27.3% in Q3 2022.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-3.03%
Tags
Rhea-AI Summary
Syra Health Corp. (NASDAQ: SYRA) announced the launch of SyraBot, a human-centric AI-backed chatbot designed to provide real-time access to information for healthcare organizations. The product aims to streamline administrative tasks, reduce workloads, and increase user satisfaction. SyraBot is available in up to 200 languages and dialects, and is accessible at a fifth-grade reading level or lower. This launch marks Syra Health's third product launch in just four weeks, demonstrating the company's commitment to revolutionizing digital health.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-7.04%
Tags
Syra Health Corp.
Nasdaq:SYRA
SYRA Rankings
SYRA Stock Data
9.31M
3.26M
30.33%
2.23%
2.2%
Dental Laboratories
Manufacturing
United States of America
CARMEL